M. Coelho

发表

[Interest of blood markers in predicting radiation-induced toxicity].

J. Solassol, M. Ozsahin, D. Azria, 2011, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

In pancreatic carcinoma, dual EGFR/HER2 targeting with cetuximab/trastuzumab is more effective than treatment with trastuzumab/erlotinib or lapatinib alone: implication of receptors' down-regulation and dimers' disruption.

C. Bascoul-Mollevi, B. Robert, A. Pèlegrin, 2012, Neoplasia.

Isolation and characterisation of a human anti-idiotypic scFv used as a surrogate tumour antigen to elicit an anti-HER-2/neu humoral response in mice

F. Roquet, I. Navarro-Teulon, A. Pèlegrin, 2004, British Journal of Cancer.